Acurx Pharmaceuticals, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
ACXP on Nasdaq
Location
259 Liberty Avenue, Staten Island, NY

Insiders trading volume in the past year

Acurx Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David P. Luci President and CEO, Director, 10%+ Owner $1.16M +$50K +4.49% Feb 5, 2025
Deluccia Robert J Director, 10%+ Owner $1.03M +$50K +5.11% Feb 5, 2025
Carl Sailer Director $144K +$25K +21% Jan 6, 2025
Joseph C. Scodari Director $28.1K +$25K +800% Jan 6, 2025
Jack H. Dean Director $28K +$10K +55.7% Jan 6, 2025
James J. Donohue Director $22.7K +$10K +78.8% Jan 6, 2025
Robert G. Shawah Chief Financial Officer Feb 5, 2025
Thomas L. Harrison Director Jun 17, 2024

Recent Insider Transactions by Companies or Individuals for Acurx Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.